Please assess the completion status of the following clinical trial:

Trial Title: Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 to 75 years old~* male or femalePathologically or cytologically proven esophageal squamous cell carcinoma~* Clinical stage II or stage III~* PG-SGA≧2~* Karnofsky performance score(KPS) ≧70~* Estimated life expectancy of at least 12 weeks~* Hemoglobin≥90.0g/dL,white blood cell count（WBC）≥ 4000 cells/mm³,Platelet count≥100,000 cells/mm³~* Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \< 2.5 times upper limit of normal,bilirubin normal~* Creatinine normal OR creatinine clearance ≥ 60 mL/min~* Patients have good compliance to treatment and follow-up of acceptance~* Forced expiratory volume in one second（FEV1） ≥ 1.5 litre or ≥ 75% of the reference value~* the functions of the heart, kidney, liver were basically normal, with no chemotherapy and radiotherapy contraindications~Exclusion Criteria:~* Patients with severely bowel function impaired or can not tolerate enteral nutrition~* Patients with serious gastrointestinal obstruction, be unable to take food by mouth and can not / do not want to a feeding tube inserted~* Patients have no risk of malnutrition~* Patients have severe malnutrition (weight loss \>10% or \<30 g/L, BMI\<18.5 kg/m2 or hemoglobin\<90 g/L before the treatment~* Patients who have severe vomiting, gastrointestinal bleeding, intestinal obstruction~* Patients can not tolerate chemotherapy and radiotherapy~* Patients who have distant metastasis~* The primary tumor or lymph node already received surgical treatment (except for biopsy);~* Patient who received radiotherapy for primary tumor or lymph node;~* Patient who received chemotherapy or immunotherapy;~* Patient who suffered from other malignant tumor;~* Patient who have taken other drug test within 1 month;~* Pregnant woman or Lactating Women and Women in productive age who refuse to take contraception in observation period;~* Subject with a severe allergic history or idiosyncratic;~* Subject with severe pulmonary and cardiopathic disease history;~* Refuse or incapable to sign the informed consent form of participating this trial;~* Drug abuse or alcohol addicted;~* Subject with a Personality or psychiatric diseases, people with no legal capacity or people with limited capacity for civil conduct;

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: EXPERIMENTAL): chemoradiotherapy with Enteral Nutrition intervention
- Arm B (Type: PLACEBO_COMPARATOR): chemoradiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).